Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2006251660 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Biftu, Tesfaye; Weber, Ann E.; Feng, Danqing; Qian, Xiaoxia; Cox, Jason

Agent Spruson & Ferguson

Pub. Number AU-B-2006251660

PCT Pub. Number WO2006/127530

Priority 60/684,567 25.05.05 US

Filing date 19 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 26 May 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/47 (2006.01) - Quinolines

A61K 31/50 (2006.01) - Pyridazines

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/127530 Priority application(s): WO2006/127530

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

26 May 2011 Application Accepted

  Published as AU-B-2006251660

22 September 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251668-Use of chalcones for the treatment of viral disorders

2006251659-Meter electronics and methods for determining void fraction of gas